Thus, the marked tesaglitazar induced reduction in FFA flux into skeletal muscles (at hyperinsulinemia) may explain the apparent enhancement in insulin stimulated oxidative glucose disposal in this tissue via the glucose-fatty acid cycle [12]. The gene discussed is INS; the disease is Hyperinsulinemia.